by Randy Miller | May 6, 2026 | FDA, FOIA, Hedge Funds, Pharmaceuticals, Short-Selling, Stock Market
FOIAengine: Assessments Include Operational, Clinical and Commercial Threats Freedom of Information Act requests to the Food and Drug Administration during March illustrated three of the primary uncertainties facing U.S. drug manufacturers and their investors: the...
by John A. Jenkins | Apr 9, 2026 | FDA, FOIA, Litigation, Medical Devices, Short-Selling, Stock Market
How FOIA Requests Signaled Problems With a “Bionic Pancreas” At a federal advisory panel meeting in 2018, a biomedical engineer named Ed Damiano stepped to the microphone – not just as a scientist. “I’m also a father,” he told regulators, describing his son’s...
by John A. Jenkins | Feb 4, 2026 | FDA, FOIA, Litigation, Pharmaceuticals, Stock Market
FOIAengine: Media Requests Were Warnings, Months Before Bad News Hit In the early days of the Covid pandemic, there was big money on the line as pharmaceutical companies scrambled to produce vaccines. The world needed a miracle. The companies that could deliver it...
by John A. Jenkins | Dec 3, 2025 | FOIA, Short-Selling, Stock Market
FOIAengine: “Cassandra Unchained” Plays to Fear and Greed Michael Burry, the reclusive contrarian who foresaw the 2007 subprime collapse and became the reluctant hero of The Big Short, has walked away from professional money management for the second — and perhaps...
by John A. Jenkins | Jul 17, 2025 | FDA, FOIA, Hedge Funds, Stock Market
FOIAengine: How a Proxy Requester Masks Its Identity On April 14, 2021, online forums where retail investors and short sellers exchange research, rumors, and trading strategies were buzzing. On Reddit and Twitter, meme stock traders were watching for the next big...
by John A. Jenkins | Jul 9, 2025 | FDA, FOIA, Hedge Funds, Stock Market
FOIAengine: Decoding How a Hedge Fund Tracks FDA Requests ExodusPoint burst onto the hedge fund scene in 2018 with the largest launch in history — raising $8.5 billion out of the gate — powered by institutional backing, an elite Wall Street pedigree, and high-profile...
